Eurazeo’s Small-Mid Buyout team is to sell in majority stake in Intech, a global market leader in the manufacturing and development of orthopaedic surgical instruments, to Montagu Private Equity.
The proposed sale is subject to US competition authority approval.
Since its investment in 2017, Eurazeo has supported Intech by providing the human and financial resources needed for its development, thus helping to more than double the company’s business in just four years, to over EUR120 million in 2021. During this period, Intech has reinforced its leadership position in spinal surgery instrument and implants while becoming one of the pioneers in the rapidly growing robotics market thanks to its R&D and prototyping capabilities, thereby gaining a strong competitive advantage.
Source: Private Equity Wire
